ArticleJournal of experimental & clinical cancer research : CR2022

UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.

Liang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.